Across TCGA pan-cancer cohorts, CTAGE12P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated CTAGE12P data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher CTAGE12P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CTAGE12P expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.
BRCA, BLCA, and CHOL are the cancer types where CTAGE12P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.